1Department of Epidemiology, University of Washington, Seattle, Washington. 2Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington. 3Department of Medicine, Samuel ...

The FDA has approved Swiss pharmaceutical company Roche’s first companion diagnostic for identifying those patients with HER2 low-metastatic breast cancer who are eligible for ENHERTU.

Cost–Effectiveness FISH versus CISH (Dual Probe ... The results are not sensitive to varying levels of HER2 overexpression in the population, as shown for a US$200 price differential and ...

The phase 1 first-in-human study is designed to assess the safety, tolerability & preliminary clinical activity of 177Lu-RAD202 in individuals with HER2-positive metastatic solid tumours. The ...

Home matches against promoted opponents give Arsenal and Liverpool’s key performers the chance to deliver big hauls in Gameweek 18 of Fantasy Premier League. Three players from each club are selected ...

The NCCN Guidelines Category of Preference is designated as “useful in certain circumstances” as a treatment option for patients with HER2-mutated tumors. This addition was based on results ...

Jazz Pharmaceuticals has claimed FDA approval for its HER2-directed bispecific antibody Ziihera as a treatment for biliary tract cancer (BTC), the first in a series of potential indications that ...